recall
savePFIZER INC recall (Cls II)
community read0 votes
Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 00409-6637-14. — Reason: Lack of Assurance of Sterility. — Status: Ongoing
view source ↗Data sources
last refreshed 1m ago
Found something off?
same company · ±60 days · 6
- recallPFIZER INC recall (Cls II)Aug 27, 2025
- recallPfizer recall (Cls II)Aug 20, 2025
- grantWEILL MEDICAL COLL OF CORNELL UNIV — Identifying Novel Roles and the Therapeutic Potential of the Thrombin Recepto...Sep 15, 2025
- approvalmarstacimab: HYMPAVZI (MARSTACIMAB-HNCQ) — FDA approvalSep 16, 2025
- recallPfizer Inc. recall (Cls II)Aug 6, 2025
- recallPfizer Inc. recall (Cls II)Aug 6, 2025
comments(0)
5-min edit window · permanent after that